427 related articles for article (PubMed ID: 1648447)
1. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.
Henderson S; Rowe M; Gregory C; Croom-Carter D; Wang F; Longnecker R; Kieff E; Rickinson A
Cell; 1991 Jun; 65(7):1107-15. PubMed ID: 1648447
[TBL] [Abstract][Full Text] [Related]
2. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.
Martin JM; Veis D; Korsmeyer SJ; Sugden B
J Virol; 1993 Sep; 67(9):5269-78. PubMed ID: 8394449
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
4. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
D'Souza B; Rowe M; Walls D
J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1.
Lu JJ; Chen JY; Hsu TY; Yu WC; Su IJ; Yang CS
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1883-92. PubMed ID: 8760440
[TBL] [Abstract][Full Text] [Related]
6. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
Röth A; Pfaff P; Lange W; Finke J
Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
[TBL] [Abstract][Full Text] [Related]
7. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
8. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.
Silins SL; Sculley TB
Int J Cancer; 1995 Jan; 60(1):65-72. PubMed ID: 7814154
[TBL] [Abstract][Full Text] [Related]
9. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines.
Birkenbach M; Liebowitz D; Wang F; Sample J; Kieff E
J Virol; 1989 Sep; 63(9):4079-84. PubMed ID: 2548016
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
Wang D; Liebowitz D; Wang F; Gregory C; Rickinson A; Larson R; Springer T; Kieff E
J Virol; 1988 Nov; 62(11):4173-84. PubMed ID: 2845129
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
D'Souza BN; Edelstein LC; Pegman PM; Smith SM; Loughran ST; Clarke A; Mehl A; Rowe M; Gélinas C; Walls D
J Virol; 2004 Feb; 78(4):1800-16. PubMed ID: 14747545
[TBL] [Abstract][Full Text] [Related]
13. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.
Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023
[TBL] [Abstract][Full Text] [Related]
14. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death.
Henderson S; Huen D; Rowe M; Dawson C; Johnson G; Rickinson A
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8479-83. PubMed ID: 8397406
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
[TBL] [Abstract][Full Text] [Related]
19. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
Arvanitakis L; Yaseen N; Sharma S
J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.
Rowe M; Peng-Pilon M; Huen DS; Hardy R; Croom-Carter D; Lundgren E; Rickinson AB
J Virol; 1994 Sep; 68(9):5602-12. PubMed ID: 7520093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
